The healthcare sector has recently witnessed a remarkable advancement in diabetes management with the arrival of copyright. This revolutionary medication, categorized as a glucagon-like peptide-1 (GLP-1) receptor agonist, provides a novel approach to managing blood sugar levels in individuals with type 2 diabetes. copyright functions by mimicking t